PMID: 41155566

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18 , 185".

Józwiak Michalina, Bauer Marta, Kamysz Wojciech, Kleczkowska Patrycja

Pharmaceuticals (Basel, Switzerland) · 2025

Vol. 18, Issue 10

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.